22 November 2024
22 November 2024
Trump's nomination of Dr Oz has raised eyebrows, as a history of big pharma financial ties and questionable science hangs over him.
RFK Jr has vowed to shake up the FDA, but the CBER head said support for the agency鈥檚 public health mission continues.
The deal includes an upfront payment in cash with added payments contingent on the achievement of certain milestones.
Pfizer's affiliated companies have exclusive rights to undertake commercialisation activities for the drug.
A review of Amneal鈥檚 NDA for the dihydroergotamine autoinjector is expected to be completed in Q2 2025.
Events like the RFK Jr nomination as US HHS head, Labour鈥檚 10-year plan, and centralised EU funding will steer the sector鈥檚 future.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
